Abstract
Medicinal plants, rich sources of valuable natural products with therapeutic potential, play a pivotal role in both traditional and modern medicine. The urgency for mass production and optimized utilization of plant secondary metabolites has intensified, particularly in response to the emergence of diseases following the COVID-19 pandemic. Groundbreaking advancements in genomics and biotechnologies have ushered in a new era of research, transforming our understanding of the biosynthesis, regulation, and manipulation of bioactive molecules in medicinal plants. This special issue serves as a convergence point for a diverse array of original research articles and reviews, collectively aiming to unveil the intricate regulatory mechanisms that govern the biosynthesis of secondary metabolites in medicinal plants. The issue delves into the exploration of the impact of both abiotic and biotic factors on the regulation of plant secondary metabolites. Furthermore, it extends its focus to innovative approaches, such as molecular breeding and synthetic biology, which provide valuable insights into modifying or enhancing the production of secondary metabolites. The special issue leverages cutting-edge techniques, including genomics, metabolomics, and microbiome characterization, to facilitate understanding the multifaceted aspects of specialized metabolism in medicinal plants. As we navigate through this scientific journey, the contributions within this special issue collectively enhance our knowledge and offer potential avenues for optimizing the production of natural products in medicinal plants.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.